🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Mark Kieh

Mark Kieh

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults”.

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Clinical Infectious Diseases(2023)10.1093/cid/ciad693

N/A

0.671DataRank · unranked

16 citations

Ken Liu, Édouard Lhomme, Julie Blie, John McCullough, Matthew Onorato +90 more

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Trials(2021)10.1186/s13063-021-05035-9

N/A

0.630DataRank · unranked

18 citations

Édouard Lhomme, Mark Kieh, Abdoul Habib Béavogui, Stephen B. Kennedy, Seydou Doumbia +91 more

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate

New England Journal of Medicine(2025)10.1056/nejmoa2501073

N/A

0.450DataRank · unranked

13 citations

Marija Zaric, Mark Kieh, Lindsey R. Baden, David Fitzpatrick, Arianna Marini +38 more

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

Emerging Microbes & Infections(2024)10.1080/22221751.2024.2432353

N/A

0.251DataRank · unranked

4 citations

Marie Alexandre, Mélanie Prague, Abdoul Habib Béavogui, Seydou Doumbia, Mark Kieh +94 more

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

EBioMedicine(2023)10.1016/j.ebiom.2023.104562

N/A

0DataRank · unranked

10 citations

Houreratou Barry, Mark Kieh, Zacchaeus Anywaine, Baimba Rogers, Seydou Doumbia +22 more

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

(2020)10.21203/rs.3.rs-30774/v1

N/A

0DataRank · unranked

0 citations

Édouard Lhomme, Mark Kieh, Abdoul Habib Béavogui, Stephen B. Kennedy, Seydou Doumbia +20 more

Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae632

N/A

0DataRank · unranked

2 citations

Irina Maljkovic Berry, Viviane Callier, Scott M. Anthony, Krystle Hensley, Jens H. Kuhn +10 more